IP Library Granted Patent US 9,670,554
Granted Patent B2
US 9,670,554 · App. 14/336,593 · Granted Jun 6, 2017

Capture probes for use in detecting the presence of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,670,554
App. No.
14/336,593
Granted
Jun 6, 2017
Kind
B2
Abstract

Oligomers useful for determining the presence of Trichomonas vaginalis in a test sample.

Claims (11)

1. A set of capture probes comprising:

a first capture probe consisting of: (i) a target-complementary sequence, the base sequence of which is selected from the group consisting of the base sequences of SEQ ID NO: 90 and SEQ ID NO: 91; and (ii) a non-complementary sequence comprising a homopolymer tail, wherein the non-complementary sequence does not stably bind to a target nucleic acid derived from Trichomonas vaginalis when the target-complementary sequence is stably hybridized to the target nucleic acid; and

a second capture probe consisting of: (i) a target-complementary sequence, the base sequence of which is selected from the group consisting of SEQ ID NO: 55 and SEQ ID NO: 56; and (ii) a non-complementary sequence comprising a homopolymer tail, wherein the non-complementary sequence does not stably bind to a target nucleic acid derived from Trichomonas vaginalis when the target-complementary sequence is stably hybridized to the target nucleic acid.

2. The set of capture probes of claim 1 , wherein the non-complementary sequence of each of the first and second capture probes comprises a spacer region for joining the target-complementary sequence to the homopolymer tail.

3. The set of capture probes of claim 1 , wherein the homopolymer tail of each of the first and second capture probes is a poly dA sequence.

4. The set of capture probes of claim 2 , wherein the homopolymer tail of each of the first and second capture probes is a poly dA sequence, and wherein the spacer region of each of the first and second capture probes is a poly dT sequence.

5. The set of capture probes of claim 1 , wherein the target-complementary sequence of each of the first and second capture probes comprises at least one ribonucleoside having 2′-O-methyl substitution to the ribofuranosyl moiety.

6. The set of capture probes of claim 2 , wherein the non-complementary sequence of each of the first and second capture probes consists of the homopolymer tail and the spacer region.

7. The set of capture probes of claim 3 , wherein the non-complementary sequence of each of the first and second capture probes consists of the homopolymer tail.

8. The set of capture probes of claim 4 , wherein the non-complementary sequence of each of the first and second probes consists of the homopolymer tail and the spacer region.

9. The set of capture probes of claim 1 , wherein the non-complementary sequence of each of the first and second probes consists of the sequence of SEQ ID NO:60.

Assignments (3)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2017
From: WEINBAUM, BARBARA S.; DOCKTER, JANEL M.; SCHRODER, ASTRID W.
To: GEN-PROBE INCORPORATED
Reel/Frame 041689/0335 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →